Antibodies Against Amyloid Beta 4 With Glycosylated in the Variable Region
    3.
    发明申请
    Antibodies Against Amyloid Beta 4 With Glycosylated in the Variable Region 有权
    抗变性区域中抗糖蛋白β4的抗体

    公开(公告)号:US20090252724A1

    公开(公告)日:2009-10-08

    申请号:US12086309

    申请日:2006-12-11

    摘要: The present invention relates to a purified antibody molecule preparation being characterized in that at least one antigen binding site comprises a glycosylated asparagine (Asn) in the variable region of the heavy chain (VH). More specifically, a pharmaceutical and a diagnostic composition comprising said antibody molecule and antibody mixtures are provided which is/are capable of specifically recognizing the β-A4 peptide/Aβ4. The present invention relates in particular to a mixture of antibodies comprising one or two glycosylated antigen binding sites with a glycosylated asparagine (Asn) in the variable region of the heavy chain, i.e. mixtures of isoforms of antibodies which comprise a glycosylated Asn in the variable region of the heavy chain (VH). Also disclosed are compositions or antibody preparations comprising the specifically glycosylated antibody isoforms. Furthermore, the pharmaceutical and diagnostic uses for these antibodies are provided. The antibody isoforms may for example be used in the pharmaceutical intervention of amyloidogenesis or amyloid-plaque formation and/or in the diagnosis of the same.

    摘要翻译: 本发明涉及纯化的抗体分子制剂,其特征在于至少一个抗原结合位点包含重链可变区(VH)中的糖基化天冬酰胺(Asn)。 更具体地,提供了包含所述抗体分子和抗体混合物的药物和诊断组合物,其能够特异性识别β-A4肽/Aβ4。 本发明特别涉及包含一个或两个糖基化抗原结合位点与重链可变区中的糖基化天冬酰胺(Asn)的抗体的混合物,即包含可变区中的糖基化Asn的抗体同种型的混合物 的重链(VH)。 还公开了包含特异性糖基化抗体同种型的组合物或抗体制剂。 此外,提供了这些抗体的药物和诊断用途。 抗体同种型可以例如用于淀粉样变形或淀粉样蛋白斑形成的药物干预和/或其诊断。

    QUADRUPLE TRANSGENIC NON-HUMAN ANIMAL
    4.
    发明申请
    QUADRUPLE TRANSGENIC NON-HUMAN ANIMAL 审中-公开
    四分子转基因非人类动物

    公开(公告)号:US20100306868A1

    公开(公告)日:2010-12-02

    申请号:US12740112

    申请日:2008-10-23

    IPC分类号: A01K67/027 C12N5/07 C12N15/89

    摘要: The present invention relates to a transgenic non-human animal whose genome comprises a) a first transgenic DNA sequence encoding a human APP Swedish or a human APP London protein, wherein said first transgenic DNA sequence is operably linked to a first promoter; b) a second transgenic DNA sequence encoding a human Presenilin 2 protein comprising a N141I substitution, wherein said second transgenic DNA sequence is operably linked to a second promoter; c) a third transgenic DNA sequence encoding a light chain of a antibody directed against the amyloid peptide, wherein said third transgenic DNA sequence is operably linked to a third promoter and; d) a forth transgenic DNA sequence encoding a heavy chain of said antibody, wherein said forth transgenic is operably linked to the third promoter or to a forth promoter, and methods for producing said animal.

    摘要翻译: 本发明涉及一种转基因非人动物,其基因组包含a)编码人APP瑞典人或人APP伦敦蛋白的第一转基因DNA序列,其中所述第一转基因DNA序列与第一启动子可操作地连接; b)编码包含N141I取代的人类早老素2蛋白的第二转基因DNA序列,其中所述第二转基因DNA序列可操作地连接到第二启动子; c)编码针对淀粉样蛋白肽的抗体的轻链的第三转基因DNA序列,其中所述第三转基因DNA序列可操作地连接到第三启动子; d)编码所述抗体重链的第四个转基因DNA序列,其中所述第四个转基因可操作地连接到第三个启动子或第四个启动子,以及用于产生所述动物的方法。

    Antibodies against amyloid beta 4 with glycosylation in the variable region
    7.
    发明授权
    Antibodies against amyloid beta 4 with glycosylation in the variable region 有权
    在可变区域中具有糖基化的淀粉样蛋白β4的抗体

    公开(公告)号:US08906370B2

    公开(公告)日:2014-12-09

    申请号:US12086309

    申请日:2006-12-11

    摘要: The present invention relates to a purified antibody molecule preparation being characterized in that at least one antigen binding site comprises a glycosylated asparagine (Asn) in the variable region of the heavy chain (VH). More specifically, a pharmaceutical and a diagnostic composition comprising said antibody molecule and antibody mixtures are provided which is/are capable of specifically recognizing the β-A4 peptide/Aβ4. The present invention relates in particular to a mixture of antibodies comprising one or two glycosylated antigen binding sites with a glycosylated asparagine (Asn) in the variable region of the heavy chain, i.e. mixtures of isoforms of antibodies which comprise a glycosylated Asn in the variable region of the heavy chain (VH). Also disclosed are compositions or antibody preparations comprising the specifically glycosylated antibody isoforms. Furthermore, the pharmaceutical and diagnostic uses for these antibodies are provided. The antibody isoforms may for example be used in the pharmaceutical intervention of amyloidogenesis or amyloid-plaque formation and/or in the diagnosis of the same.

    摘要翻译: 本发明涉及纯化的抗体分子制剂,其特征在于至少一个抗原结合位点包含重链可变区(VH)中的糖基化天冬酰胺(Asn)。 更具体地,提供了包含所述抗体分子和抗体混合物的药物和诊断组合物,其能够特异性识别Aβ-4肽/ A&bgr; 4。 本发明特别涉及包含一个或两个糖基化抗原结合位点与重链可变区中的糖基化天冬酰胺(Asn)的抗体的混合物,即包含可变区中的糖基化Asn的抗体同种型的混合物 的重链(VH)。 还公开了包含特异性糖基化抗体同种型的组合物或抗体制剂。 此外,提供了这些抗体的药物和诊断用途。 抗体同种型可以例如用于淀粉样变形或淀粉样蛋白斑形成的药物干预和/或其诊断。